Approval · Notice of Compliance 24878 · 2020
CINRYZE: Notice of Compliance 24878
Issued December 18, 2020
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 24878
- Date
- December 18, 2020
- Company
- Takeda Canada IncorporatedToronto, Ontario, Canada
- Product type
- Biologic
- Submission
- New Drug Submission (NDS)
- Submission class
- Labelling Only
- Reason
- Transfer of drug identification number, labelling updates
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| CINRYZE | 02395371 | Cancelled Post Market |
Medicinal ingredients
- C1 ESTERASE INHIBITOR (HUMAN) 500 UNIT per VIAL